The cellular immunotherapy of cancer: Current and potential uses of interleukin-2

Paul M. Sondel; Jacquelyn A. Hank; Peter C. Kohler; Jeff A. Sosman; Gilda Weil-Hillman; Paul Fisch; Fritz H. Bach

doi:10.1016/S1040-8428(89)80008-3

The cellular immunotherapy of cancer: Current and potential uses of interleukin-2

Paul M. Sondel^*, Jacquelyn A. Hank, Peter C. Kohler, Jeff A. Sosman, Gilda Weil-Hillman, Paul Fisch, Fritz H. Bach

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Original language	English (US)
Pages (from-to)	125-147
Number of pages	23
Journal	Critical Reviews in Oncology and Hematology
Volume	9
Issue number	2
DOIs	https://doi.org/10.1016/S1040-8428(89)80008-3
State	Published - 1989

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/S1040-8428(89)80008-3

Cite this

@article{3d54eb78778c44d7bac0edd39405d2ff,

title = "The cellular immunotherapy of cancer: Current and potential uses of interleukin-2",

author = "Sondel, {Paul M.} and Hank, {Jacquelyn A.} and Kohler, {Peter C.} and Sosman, {Jeff A.} and Gilda Weil-Hillman and Paul Fisch and Bach, {Fritz H.}",

year = "1989",

doi = "10.1016/S1040-8428(89)80008-3",

language = "English (US)",

volume = "9",

pages = "125--147",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - The cellular immunotherapy of cancer

T2 - Current and potential uses of interleukin-2

AU - Sondel, Paul M.

AU - Hank, Jacquelyn A.

AU - Kohler, Peter C.

AU - Sosman, Jeff A.

AU - Weil-Hillman, Gilda

AU - Fisch, Paul

AU - Bach, Fritz H.

PY - 1989

Y1 - 1989

UR - http://www.scopus.com/inward/record.url?scp=0024353384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024353384&partnerID=8YFLogxK

U2 - 10.1016/S1040-8428(89)80008-3

DO - 10.1016/S1040-8428(89)80008-3

M3 - Article

C2 - 2663205

AN - SCOPUS:0024353384

VL - 9

SP - 125

EP - 147

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 2

ER -